TY  - GEN
AU  - Zhu,Jian
AU  - Wang,Yuyan
AU  - Duan,Jianchun
AU  - Bai,Hua
AU  - Wang,Zhijie
AU  - Wei,Lai
AU  - Zhao,Jun
AU  - Zhuo,Minglei
AU  - Wang,Shuhang
AU  - Yang,Lu
AU  - An,Tongtong
AU  - Wu,Meina
AU  - Wang,Jie
TI  - DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer
SN  - 1756-9966
PY  - 2013///0523
KW  - Adaptor Proteins, Signal Transducing
KW  - Aged
KW  - Biomarkers, Pharmacological
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - DNA Methylation
KW  - genetics
KW  - Disease-Free Survival
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Eye Proteins
KW  - Female
KW  - Humans
KW  - Male
KW  - Membrane Proteins
KW  - Middle Aged
KW  - Mutation
KW  - Neoplasm Staging
KW  - Protein Kinase Inhibitors
KW  - administration & dosage
KW  - Treatment Outcome
KW  - Wnt Signaling Pathway
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/1756-9966-31-80
ER  -